Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02210689 · ClinicalTrials.gov registry record · Phase 3

A Multi-center, Double-blind, Randomized Study, Comparing Clindamycin Phosphate Vaginal Cream 2% (Watson Laboratories, Inc.) to Clindesse® (Ther-Rx™, Clindamyin Phosphate Vaginal Cream 2%) and Both Active Treatments to a Placebo Control in the Treatment of Bacterial Vaginosis in Non-pregnant Women

A Phase 3 study of Bacterial Vaginosis and Signs and Symptoms to be Evaluated and Recorded Include, sponsored by Actavis.

Completed
Registry status
Phase 3
Development phase
604
Enrollment target
18
Study locations

NCT02210689 is a Phase 3 study of Bacterial Vaginosis and Signs and Symptoms to be Evaluated and Recorded Include that has completed, run by Actavis. The registered enrollment target is 604 participants, above the 298-participant average among 15 other Bacterial Vaginosis trials with a reported enrollment target (103% higher). The trial reports 18 study locations across 12 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02210689, a Phase 3 study of Bacterial Vaginosis and Signs and Symptoms to be Evaluated and Recorded Include, has completed, sponsored by Actavis.

COMPLETED
Registry status
Phase 3
Development phase
604 participants
Enrollment target
18
Study locations

Study Summary

A multi-center, double-blind, randomized, placebo controlled, parallel-group study, comparing Clindamycin phosphate vaginal cream 2% (Watson Laboratories, Inc.) to Clindesse® (Ther-Rx™, Clindamyin Phosphate Vaginal Cream 2%) and both active treatments to a placebo control in the treatment of bacterial vaginosis in non-pregnant women.

Conditions Studied

Bacterial Vaginosis Signs and Symptoms to be Evaluated and Recorded Include Vaginal Discharge Color, Odor, and Consistency Vulvovaginal Itching and Irritation (Subjective) Absent, Mild, Moderate, or Severe Vulvovaginal Inflammation (Objective) Absent, Mild, Moderate, or Severe

Interventions

  • OTHER placebo
  • DRUG clindamycin phosphate vaginal cream 2%

Study Locations (18)

Florida

  • Akesis Investigator site 1 - Boynton Beach
  • Akesis investigator site 14 - North Miami
  • Akesis investigator site 17 - Sanford
  • Akesis investigator site 8 - Sunrise
  • Akesis Investigator site 10 - West Palm Beach

California

  • Akesis Investigator site 12 - La Mesa
  • Akesis investigator site 6 - San Diego

Republica Dominicana

  • Akesis investigator site 3 - Santo Domingo
  • Akesis investigator site 4 - Santo Domingo

Alabama

  • Akesis Investigator site 5 - Birmingham

Georgia

  • Akesis Investigator site 9 - Roswell

Louisiana

  • Akesis Investigator site 15 - Metairie

New Jersey

  • Akesis investigator site 16 - Lawrenceville

New York

  • Akesis investigator site 11 - Port Jefferson

Trial Details

FieldValue
Enrollment Target 604 participants
Start Date 2014-01
Est. Completion 2014-12
Phase Phase 3

Sponsor

Actavis

79 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT02210689

The ClinicalTrials.gov registry entry for NCT02210689 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 604 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 298-participant average among 15 other Bacterial Vaginosis trials with a reported enrollment target (103% higher). The listed sponsor is Actavis, which has 79 total studies on file at ClinicalTrials.gov.

The record links to 5 conditions, with Bacterial Vaginosis appearing as the primary indexed condition, and to 2 interventions - of which placebo is the first listed.

NCT02210689 reports 18 study locations spanning 12 distinct geographic areas - top geographies include Florida, California, Republica Dominicana.

Frequently Asked Questions

What is clinical trial NCT02210689 about?

NCT02210689 is a clinical study titled "A Multi-center, Double-blind, Randomized Study, Comparing Clindamycin Phosphate Vaginal Cream 2% (Watson Laboratories, Inc.) to Clindesse® (Ther-Rx™, Clindamyin Phosphate Vaginal Cream 2%) and Both Active Treatments to a Placebo Control in the Treatment of Bacterial Vaginosis in Non-pregnant Women". A multi-center, double-blind, randomized, placebo controlled, parallel-group study, comparing Clindamycin phosphate vaginal cream 2% (Watson Laboratories, Inc.) to Clindesse® (Ther-Rx™, Clindamyin Phosphate Vaginal Cream 2%) and both active treatments to a placebo control in the treatment of bacteri...

What is the current status of trial NCT02210689?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 604 participants. The study started on 2014-01. Estimated completion is 2014-12.

What conditions does trial NCT02210689 study?

This clinical trial studies the following conditions: Bacterial Vaginosis, Signs and Symptoms to be Evaluated and Recorded Include, Vaginal Discharge Color, Odor, and Consistency, Vulvovaginal Itching and Irritation (Subjective) Absent, Mild, Moderate, or Severe, Vulvovaginal Inflammation (Objective) Absent, Mild, Moderate, or Severe.

What interventions are being tested in trial NCT02210689?

The interventions under investigation include: placebo (OTHER), clindamycin phosphate vaginal cream 2% (DRUG).

Who is sponsoring clinical trial NCT02210689?

This trial is sponsored by Actavis, which has 79 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02210689 being conducted?

This trial has 18 study locations across Alabama, California, Florida, Georgia, Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Bacterial Vaginosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Bacterial Vaginosis

All registered trials for this condition

Signs and Symptoms to be Evaluated and Recorded Include

All registered trials for this condition

Alabama

All trials with a study site in Alabama

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.